本文關(guān)鍵詞： 胃癌 腫瘤干細(xì)胞 CD 球形體　出處：《中華腫瘤防治雜志》2017年03期 　論文類型：期刊論文

【摘要】：目的腫瘤干細(xì)胞(cancer stem cells,CSCs)在惡性腫瘤的發(fā)生發(fā)展中起著重要作用,且是腫瘤耐藥及復(fù)發(fā)的根源。本研究探討CSCs表面標(biāo)記蛋白CD44在分離及鑒定胃癌干細(xì)胞中的重要作用。方法收集2015-11-06-2015-12-01華中科技大學(xué)同濟(jì)醫(yī)學(xué)院附屬同濟(jì)醫(yī)院3例胃癌患者手術(shù)標(biāo)本。首先采用膠原酶消化法獲取胃癌細(xì)胞,部分細(xì)胞分別貼壁及懸浮培養(yǎng),并采用免疫熒光及流式分析的方法檢測(cè)胃癌球形體中CD44的表達(dá)情況。部分細(xì)胞采用流式細(xì)胞儀分選得到CD44~+及CD44~-胃癌細(xì)胞,并通過無血清懸浮培養(yǎng)法比較兩群細(xì)胞的球形體形成能力。結(jié)果免疫熒光顯示,CD44蛋白在球形體中高表達(dá);流式分析發(fā)現(xiàn),貼壁的原代胃癌細(xì)胞中CD44~+細(xì)胞的比例為(30.73±7.6)%,而球形體中CD44~+細(xì)胞的比例高達(dá)(56.4±5.58)%,差異有統(tǒng)計(jì)學(xué)意義,P=0.009。球形體形成實(shí)驗(yàn)結(jié)果表明,與CD44~-細(xì)胞相比,CD44~+胃癌細(xì)胞具有更強(qiáng)的球形體形成能力,1 000個(gè)CD44~+及CD44~-胃癌細(xì)胞分別形成(14.33±2.52)和(1.67±0.58)個(gè)球形體,差異有統(tǒng)計(jì)學(xué)意義,P=0.001。通過比較發(fā)現(xiàn),球形體培養(yǎng)對(duì)胃癌干細(xì)胞的富集效率為0.3%,而CD44對(duì)胃癌干細(xì)胞的富集效率為1.4%。結(jié)論 CD44是胃癌干細(xì)胞的表面標(biāo)記蛋白,其可能成為胃癌靶向治療的可靠靶標(biāo)。
[Abstract]:Objective Cancer stem cell stem cells play an important role in the occurrence and development of malignant tumor. In this study, we investigated the important role of CSCs surface marker protein CD44 in the isolation and identification of gastric cancer stem cells. Methods 2015-11-06-2015-. 12-01 gastric cancer cells were obtained by collagenase digestion from 3 patients with gastric cancer in Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology. Some of the cells were adhered to the wall and cultured in suspension. The expression of CD44 in the spherical body of gastric cancer was detected by immunofluorescence and flow cytometry. CD44 ~ and CD44 ~-gastric cancer cells were isolated by flow cytometry. The ability of spheroid formation of the two groups of cells was compared by serum-free suspension culture. Results Immunofluorescence showed that CD44 protein was highly expressed in the spheroidium. The percentage of CD44 ~ cells in primary gastric cancer cells was 30.73 鹵7.6%. The percentage of CD44~ cells in the globular body was 56.4 鹵5.58. The difference was statistically significant. Compared with CD44- cells, CD44- cells have stronger spheroidogenesis ability. 1 000 CD44 ~ and CD44 ~-gastric cancer cells formed 14. 33 鹵2. 52) and 1. 67 鹵0. 58) spheroids, respectively. The difference was statistically significant. P0. 001. by comparison, it was found that the enrichment rate of gastric cancer stem cells in spheroid culture was 0.3%. Conclusion CD44 is the surface marker protein of gastric cancer stem cells, and it may be a reliable target for gastric cancer targeted therapy.
【作者單位】： 華中科技大學(xué)同濟(jì)醫(yī)學(xué)院附屬同濟(jì)醫(yī)院腫瘤中心;
【基金】：國家自然科學(xué)基金(81201820)
【分類號(hào)】：R735.2
【正文快照】： 中華腫瘤防治雜志,2017,24(3):173-177Chin J Cancer Prev Treat,2017,24(3):173-177自從20世紀(jì)末腫瘤干細(xì)胞(cancer stem cells,CSCs)理論被提出后,其在很大程度上改變了惡性腫瘤的臨床診斷思維和治療方法。該理論認(rèn)為CSCs是腫瘤組織中存在的一小群具有干細(xì)胞的自我更新和分

【相似文獻(xiàn)】

相關(guān)期刊論文 前8條

1 彭士云;郝慧婷;郁向靜;;不同方法檢測(cè)乳腺癌患者體內(nèi)CD44表達(dá)的分析[J];中國衛(wèi)生檢驗(yàn)雜志;2012年06期

2 郝慧婷;彭士云;趙婷;;乳腺癌患者外周血淋巴細(xì)胞中CD44表達(dá)的臨床意義[J];實(shí)用癌癥雜志;2012年02期

3 王守練;姜波健;;胃癌細(xì)胞表面標(biāo)志CD44表達(dá)生物學(xué)意義的研究進(jìn)展[J];中華腫瘤防治雜志;2012年24期

4 黃文斌,彭敦發(fā),齊瓊;胃癌CD44表達(dá)及其臨床意義的研究[J];皖南醫(yī)學(xué)院學(xué)報(bào);2000年03期

5 李增才;俞永忠;許正昌;;VEGF和CD44表達(dá)與乳腺癌分期的相關(guān)性研究[J];現(xiàn)代腫瘤醫(yī)學(xué);2007年09期

6 姚和瑞;李志華;陳煥清;賈衛(wèi)娟;龔暢;蘇逢錫;;乳腺癌組織CD44表達(dá)及其臨床意義的探討[J];中華腫瘤防治雜志;2009年11期

7 吳海濤,王薇,許良中,朱為萍;喉癌nm23、Cath-D和CD44表達(dá)與預(yù)后的相關(guān)因素分析[J];耳鼻咽喉頭頸外科;2000年04期

8 ;[J];;年期

，

本文編號(hào)：1484768